Seroprevalence of Alphaviruses (


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
20 07 2023
Historique:
received: 22 06 2023
revised: 13 07 2023
accepted: 17 07 2023
medline: 31 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

The presence of alphaviruses, such as chikungunya virus (CHIKV), has never been reported in Mauritania. We assessed the seroprevalence of CHIKV among Nouakchott residents. A cross-sectional study involving 1300 non-febrile patients consulting at the Nouakchott hospital center was conducted between January and June 2021. The presence of anti-CHIKV IgG and neutralizing antibodies against CHIKV, O'nyong-nyong virus (ONNV), and Semliki Forest virus (SFV) was determined by an enzyme-linked immunosorbent assay (ELISA) and a serum neutralization test, respectively, and the associated risk factors were investigated. Of the 1300 study participants, serological evidence of previous exposure to CHIKV was observed in 37 individuals (2.8%). Sex, age, reported use of repellants, and bed net ownership and usage were not associated with CHIKV seropositivity. Our results showed the co-circulation of two other alphaviruses, ONNV and SFV, in Nouakchott in 30 (2.3%) individuals. This is the first study that documents the co-circulation of CHIKV, ONNV, and SFV in Mauritania, albeit at low prevalence. Surveillance and routine testing for alphaviruses and other arboviruses in symptomatic patients should be implemented in health facilities to assess the health burden associated with these viruses. Efforts should also be made to strengthen the vector control measures.

Identifiants

pubmed: 37515274
pii: v15071588
doi: 10.3390/v15071588
pmc: PMC10385508
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Pathogens. 2022 Jul 04;11(7):
pubmed: 35890007
Public Health. 2019 Jan;166:79-88
pubmed: 30468973
Parasit Vectors. 2017 Jan 19;10(1):35
pubmed: 28103955
J Gen Virol. 2000 Feb;81(Pt 2):471-9
pubmed: 10644846
Am J Trop Med Hyg. 1990 Apr;42(4):386-93
pubmed: 2158754
Nat Microbiol. 2019 May;4(5):854-863
pubmed: 30833735
Antiviral Res. 2019 Dec;172:104611
pubmed: 31545982
PLoS Negl Trop Dis. 2021 Aug 30;15(8):e0009735
pubmed: 34460820
Open Forum Infect Dis. 2017 Jun 16;4(2):ofx087
pubmed: 28638845
Int J Infect Dis. 2021 Oct;111:271-280
pubmed: 34428546
PLoS One. 2020 Jul 1;15(7):e0235322
pubmed: 32609784
Emerg Infect Dis. 2001 Nov-Dec;7(6):1052-4
pubmed: 11747742
Pathog Glob Health. 2020 May;114(3):111-116
pubmed: 32191166
Am J Trop Med Hyg. 1999 Feb;60(2):281-6
pubmed: 10072152
Open Forum Infect Dis. 2017 Dec 02;5(1):ofx259
pubmed: 29354659
PLoS Negl Trop Dis. 2020 Sep 3;14(9):e0008549
pubmed: 32881913
Int J Environ Health Res. 2022 Jan;32(1):191-206
pubmed: 32279543
Int J Infect Dis. 2021 Mar;104:183-188
pubmed: 33373719
Int J Environ Res Public Health. 2014 Jan 09;11(1):903-18
pubmed: 24413703
Malar J. 2021 Sep 8;20(1):364
pubmed: 34493280
Parasit Vectors. 2017 Mar 27;10(1):164
pubmed: 28347325
Viruses. 2022 Jun 13;14(6):
pubmed: 35746757
Nat Commun. 2018 Mar 13;9(1):1046
pubmed: 29535306
PLoS Negl Trop Dis. 2022 Apr 15;16(4):e0010203
pubmed: 35427361
PLoS Negl Trop Dis. 2021 Mar 4;15(3):e0009055
pubmed: 33661908
Antiviral Res. 2019 Jun;166:66-81
pubmed: 30905821
Pathog Glob Health. 2017 Sep;111(6):271-275
pubmed: 28829253
PLoS Negl Trop Dis. 2021 Apr 28;15(4):e0009337
pubmed: 33909610
Pathogens. 2019 Jul 27;8(3):
pubmed: 31357631
Emerg Infect Dis. 2020 Apr;26(4):817-818
pubmed: 32187505
PLoS Negl Trop Dis. 2015 Jul 16;9(7):e0003906
pubmed: 26181441
Braz J Infect Dis. 2020 Jan - Feb;24(1):1-6
pubmed: 32001210
N Engl J Med. 2015 Jul 2;373(1):93-4
pubmed: 26132957
Nat Commun. 2021 Nov 18;12(1):6735
pubmed: 34795213
Euro Surveill. 2014 Mar 13;19(10):
pubmed: 24650864
PLoS Negl Trop Dis. 2015 Feb 06;9(2):e0003436
pubmed: 25658762
Bull Soc Pathol Exot. 1999 May;92(2):79-82
pubmed: 10399593
PLoS One. 2021 Jul 8;16(7):e0253953
pubmed: 34237098
Emerg Infect Dis. 2004 Dec;10(12):2143-9
pubmed: 15663851
J Med Entomol. 2015 Jul;52(4):730-3
pubmed: 26335483
J Infect Dis. 2016 Dec 15;214(suppl 5):S436-S440
pubmed: 27920169
PLoS Negl Trop Dis. 2021 Oct 25;15(10):e0009829
pubmed: 34695119
Biochem Biophys Res Commun. 2017 Oct 28;492(4):608-616
pubmed: 28189673
Lancet. 1985 Jan 12;1(8420):116
pubmed: 2857020
Emerg Infect Dis. 2016 Feb;22(2):340-2
pubmed: 26812625
Trans R Soc Trop Med Hyg. 1990 Jul-Aug;84(4):573-6
pubmed: 2128671
Antiviral Res. 2013 Sep;99(3):345-70
pubmed: 23811281
J Vector Borne Dis. 2013 Dec;50(4):302-6
pubmed: 24499854
PLoS Negl Trop Dis. 2019 Sep 5;13(9):e0007047
pubmed: 31487279
Malar J. 2023 Jan 17;22(1):18
pubmed: 36650533
Ann Inst Pasteur Virol. 1988 Jul-Sep;139(3):307-8
pubmed: 3207509
Malar J. 2015 Mar 04;14:100
pubmed: 25880759

Auteurs

Bedia Abdoullah (B)

Unité de Recherche Génomes et Milieux (GEMI), Université de Nouakchott, Nouveau Campus Universitaire, Nouakchott BP 5026, Mauritania.

Guillaume André Durand (GA)

National Reference Center for Arboviruses, National Institute of Health and Medical Research (Inserm) and French Armed Forces Biomedical Research Institute (IRBA), 13005 Marseille, France.
Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207), 13005 Marseille, France.

Leonardo K Basco (LK)

Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, 13005 Marseille, France.
IHU-Méditerranée Infection, 13005 Marseille, France.

Ahmed El Bara (A)

Institut National de Recherche en Santé Publique, Nouakchott BP 695, Mauritania.

Mohamed Abdallahi Bollahi (MA)

Institut National de Recherche en Santé Publique, Nouakchott BP 695, Mauritania.

Laurent Bosio (L)

National Reference Center for Arboviruses, National Institute of Health and Medical Research (Inserm) and French Armed Forces Biomedical Research Institute (IRBA), 13005 Marseille, France.
Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207), 13005 Marseille, France.

Manon Geulen (M)

National Reference Center for Arboviruses, National Institute of Health and Medical Research (Inserm) and French Armed Forces Biomedical Research Institute (IRBA), 13005 Marseille, France.
Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207), 13005 Marseille, France.

Sébastien Briolant (S)

Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, 13005 Marseille, France.
IHU-Méditerranée Infection, 13005 Marseille, France.
Unité de Parasitologie Entomologie, Département de Microbiologie et Maladies Infectieuses, Institut de Recherche Biomédicale des Armées (IRBA), 13005 Marseille, France.

Ali Ould Mohamed Salem Boukhary (AOMS)

Unité de Recherche Génomes et Milieux (GEMI), Université de Nouakchott, Nouveau Campus Universitaire, Nouakchott BP 5026, Mauritania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH